Latest News of ITCI
Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long
By Yahoo! Finance |
2 months ago
Intra-Cellular Therapies, Inc., a biopharmaceutical company, is approaching breakeven with analysts predicting profitability in 2025 after a loss of US$140m in the previous year. The company's debt-fr...